Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients

Eur Respir Rev. 2013 Mar 1;22(127):93-5. doi: 10.1183/09059180.00001912.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Disease Progression
  • Drug Administration Schedule
  • Fatal Outcome
  • Female
  • Humans
  • Iatrogenic Disease*
  • Lenalidomide
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Pneumonia / chemically induced*
  • Pneumonia / diagnosis
  • Pneumonia / therapy
  • Thalidomide / administration & dosage
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Time Factors
  • Tomography, X-Ray Computed

Substances

  • Angiogenesis Inhibitors
  • Thalidomide
  • Lenalidomide